# Reviews

- **[Tang et al.](https://arxiv.org/pdf/2402.08703.pdf)**
- **[Orguiera et al.](https://doi.org/10.3389/frhem.2024.1305741)**

- **AI Deep Learning Generative Models for Drug Discovery** [2024]  
    Bai, Qifeng, Jian Ma, and Tingyang Xu.  
    **[Applications of Generative AI. Cham: Springer International Publishing (2024)](https://link.springer.com/chapter/10.1007/978-3-031-46238-2_23)**

- **Deep Generative Models in De Novo Drug Molecule Generation** [2024]  
    Xiangru Tang, Howard Dai, Elizabeth Knight, Fang Wu, Yunyang Li, Tianxiao Li, Mark Gerstein  
    **[arXiv:2402.08703 (2024)](https://arxiv.org/abs/2402.08703)** | **[code](https://github.com/gersteinlab/GenAI4Drug)**

- **Deep Generative Models in De Novo Drug Molecule Generation** [2023]  
    Chao Pang, Jianbo Qiao, Xiangxiang Zeng, Quan Zou, and Leyi Wei*  
    **[J. Chem. Inf. Model. (2023)](https://doi.org/10.1021/acs.jcim.3c01496)**

- **The Hitchhiker’s Guide to Deep Learning Driven Generative Chemistry** [2023]  
    Yan Ivanenkov, Bogdan Zagribelnyy, Alex Malyshev, Sergei Evteev, Victor Terentiev, Petrina Kamya, Dmitry Bezrukov, Alex Aliper, Feng Ren, and Alex Zhavoronkov  
    **[ACS Med. Chem. Lett. (2023)](https://doi.org/10.1021/acsmedchemlett.3c00041)**

- **Quantum computing for near-term applications in generative chemistry and drug discovery** [2023]  
    Pyrkov, Alexey, Alex Aliper, Dmitry Bezrukov, Yen-Chu Lin, Daniil Polykovskiy, Petrina Kamya, Feng Ren, and Alex Zhavoronkov.  
    **[Drug Discovery Today (2023)](https://doi.org/10.1016/j.drudis.2023.103675)**

- **A Systematic Survey in Geometric Deep Learning for Structure-based Drug Design**[2023]  
    Zaixi Zhang, Jiaxian Yan, Qi Liu, Enhong Chen  
    **[arXiv:2306.11768v2](https://arxiv.org/abs/2306.11768)**

- **How will generative AI disrupt data science in drug discovery?**[2023]  
    Vert, JP.  
    **[Nat Biotechnol (2023)](https://doi.org/10.1038/s41587-023-01789-6)**

- **Generative Models as an Emerging Paradigm in the Chemical Sciences**[2023]  
    Anstine, Dylan M., and Olexandr Isayev.  
    **[JACS (2023)](https://pubs.acs.org/doi/10.1021/jacs.2c13467)**

- **Chemical language models for de novo drug design: Challenges and opportunities**[2023]  
    Grisoni, Francesca.  
    **[Current Opinion in Structural Biology 79 (2023)](https://doi.org/10.1016/j.sbi.2023.102527)**

- **Artificial intelligence in multi-objective drug design**[2023]  
    Luukkonen, Sohvi, Helle W. van den Maagdenberg, Michael TM Emmerich, and Gerard JP van Westen.  
    **[Current Opinion in Structural Biology 79 (2023)](https://doi.org/10.1016/j.sbi.2023.102537)**

- **Integrating structure-based approaches in generative molecular design**[2023]  
    Thomas, Morgan, Andreas Bender, and Chris de Graaf.  
    **[Current Opinion in Structural Biology 79 (2023)](https://doi.org/10.1016/j.sbi.2023.102559)**

- **Open data and algorithms for open science in AI-driven molecular informatics**[2023]  
    Brinkhaus, Henning Otto, Kohulan Rajan, Jonas Schaub, Achim Zielesny, and Christoph Steinbeck.  
    **[Current Opinion in Structural Biology 79 (2023)](https://doi.org/10.1016/j.sbi.2023.102542)**

- **Structure-based drug design with geometric deep learning**[2023]  
    Isert, Clemens, Kenneth Atz, and Gisbert Schneider.  
    **[Current Opinion in Structural Biology 79 (2023)](https://doi.org/10.1016/j.sbi.2023.102548)**

- **MolGenSurvey: A Systematic Survey in Machine Learning Models for Molecule Design**[2022]  
    Du, Yuanqi, Tianfan Fu, Jimeng Sun, and Shengchao Liu.  
    **[arXiv:2203.14500 (2022)](https://arxiv.org/abs/2203.14500)**

- **Deep generative molecular design reshapes drug discovery**[2022]  
    Zeng, Xiangxiang, Fei Wang, Yuan Luo, Seung-gu Kang, Jian Tang, Felice C. Lightstone, Evandro F. Fang, Wendy Cornell, Ruth Nussinov, and Feixiong Cheng.  
    **[Cell Reports Medicine (2022)](https://doi.org/10.1016/j.xcrm.2022.100794)**

- **Structure-based drug discovery with deep learning**[2022]  
    Özçelik, Rıza, Derek van Tilborg, José Jiménez-Luna, and Francesca Grisoni.  
    **[ChemBioChem (2022)](https://doi.org/10.1002/cbic.202200776)**

- **Generative models for molecular discovery: Recent advances and challenges**[2022]  
    Bilodeau, Camille, Wengong Jin, Tommi Jaakkola, Regina Barzilay, and Klavs F. Jensen.  
    **[Computational Molecular Science 12.5 (2022)](https://doi.org/10.1002/wcms.1608)**

- **Assessing Deep Generative Models in Chemical Composition Space**[2022]  
    Türk, Hanna, Elisabetta Landini, Christian Kunkel, Johannes T. Margraf, and Karsten Reuter.  
    **[Chemistry of Materials 34.21 (2022)](https://doi.org/10.1021/acs.chemmater.2c01860)**

- **Generative machine learning for de novo drug discovery: A systematic review**[2022]  
    Martinelli, Dominic.  
    **[Computers in Biology and Medicine 145 (2022)](https://doi.org/10.1016/j.compbiomed.2022.105403)**

- **Docking-based generative approaches in the search for new drug candidates**[2022]  
    Danel, Tomasz, Jan Łęski, Sabina Podlewska, and Igor T. Podolak.  
    **[Drug Discovery Today (2022)](https://doi.org/10.1016/j.drudis.2022.103439)**

- **Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models**[2022]  
    Xie, Weixin, Fanhao Wang, Yibo Li, Luhua Lai, and Jianfeng Pei.  
    **[J. Chem. Inf. Model. 2022, 62, 10, 2269–2279](https://pubs.acs.org/doi/10.1021/acs.jcim.2c00042)**

- **Deep learning to catalyze inverse molecular design**[2022]  
    Alshehri, Abdulelah S., and Fengqi You.  
    **[Chemical Engineering Journal 444 (2022)](https://doi.org/10.1016/j.cej.2022.136669)**

- **AI in 3D compound design**[2022]  
    Hadfield, Thomas E., and Charlotte M. Deane.  
    **[Current Opinion in Structural Biology 73 (2022)](https://doi.org/10.1016/j.sbi.2021.102326)**

- **Deep learning approaches for de novo drug design: An overview**[2021]  
    Wang, Mingyang, Zhe Wang, Huiyong Sun, Jike Wang, Chao Shen, Gaoqi Weng, Xin Chai, Honglin Li, Dongsheng Cao, and Tingjun Hou.  
    **[Current Opinion in Structural Biology 72 (2022)](https://doi.org/10.1016/j.sbi.2021.10.001)**

- **Generative chemistry: drug discovery with deep learning generative models**[2021]  
    Bian, Yuemin, and Xiang-Qun Xie.  
    **[Journal of Molecular Modeling 27 (2021)](https://link.springer.com/article/10.1007/s00894-021-04674-8)**

- **Generative Deep Learning for Targeted Compound Design**[2021]  
    Sousa, Tiago, João Correia, Vítor Pereira, and Miguel Rocha.  
    **[J. Chem. Inf. Model. 2021, 61, 11, 5343–5361](https://pubs.acs.org/doi/10.1021/acs.jcim.0c01496)**

- **Generative Models for De Novo Drug Design**[2021]  
    Tong, Xiaochu, Xiaohong Liu, Xiaoqin Tan, Xutong Li, Jiaxin Jiang, Zhaoping Xiong, Tingyang Xu, Hualiang Jiang, Nan Qiao, and Mingyue Zheng.  
    **[Journal of Medicinal Chemistry 64.19 (2021)](https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00927)**

- **Molecular design in drug discovery: a comprehensive review of deep generative models**[2021]  
    Cheng, Yu, Yongshun Gong, Yuansheng Liu, Bosheng Song, and Quan Zou.  
    **[Briefings in bioinformatics 22.6 (2021)](https://doi.org/10.1093/bib/bbab344)**

- **De novo molecular design and generative models**[2021]  
    Meyers, Joshua, Benedek Fabian, and Nathan Brown.  
    **[Drug Discovery Today 26.11 (2021)](https://doi.org/10.1016/j.drudis.2021.05.019)**

- **Deep learning for molecular design—a review of the state of the art**[2019]  
    Elton, Daniel C., Zois Boukouvalas, Mark D. Fuge, and Peter W. Chung.  
    **[Molecular Systems Design & Engineering 4.4 (2019)](https://pubs.rsc.org/en/content/articlelanding/2019/me/c9me00039a)**

- **Inverse molecular design using machine learning: Generative models for matter engineering**[2018]  
    Sanchez-Lengeling, Benjamin, and Alán Aspuru-Guzik.  
    **[Science 361.6400 (2018)](https://www.science.org/doi/10.1126/science.aat2663)**
